BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 3480379)

  • 21. Occurrence of and exposure to N-nitrosamines in Sweden: a review.
    Osterdahl BG
    IARC Sci Publ; 1991; (105):235-7. PubMed ID: 1855859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users.
    Nair J; Ohshima H; Nair UJ; Bartsch H
    Crit Rev Toxicol; 1996; 26(2):149-61. PubMed ID: 8688158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
    Stepanov I; Jensen J; Hatsukami D; Hecht SS
    Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines.
    Stanfill SB; Connolly GN; Zhang L; Jia LT; Henningfield JE; Richter P; Lawler TS; Ayo-Yusuf OA; Ashley DL; Watson CH
    Tob Control; 2011 May; 20(3):e2. PubMed ID: 21109685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unusually high levels of carcinogenic tobacco-specific nitrosamines in Sudan snuff (toombak).
    Idris AM; Nair J; Ohshima H; Friesen M; Brouet I; Faustman EM; Bartsch H
    Carcinogenesis; 1991 Jun; 12(6):1115-8. PubMed ID: 2044192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of nicotine, pH, and moisture content of six U.S. commercial moist snuff products--Florida, January-February 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 May; 48(19):398-401. PubMed ID: 10366135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tobacco specific N-nitrosamines: occurrence and bioassays.
    Hoffmann D; Adams JD; Brunnemann KD; Rivenson A; Hecht SS
    IARC Sci Publ; 1982; (41):309-18. PubMed ID: 6890526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smokeless tobacco: association with increased cancer risk.
    Mattson ME; Winn DM
    NCI Monogr; 1989; (8):13-6. PubMed ID: 2654650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Swedish snus and the Sudanese toombak: are they different?
    Idris AM; Ibrahim SO; Vasstrand EN; Johannessen AC; Lillehaug JR; Magnusson B; Wallström M; Hirsch JM; Nilsen R
    Oral Oncol; 1998 Nov; 34(6):558-66. PubMed ID: 9930371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical characterization of domestic oral tobacco products: total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines.
    Lawler TS; Stanfill SB; Zhang L; Ashley DL; Watson CH
    Food Chem Toxicol; 2013 Jul; 57():380-6. PubMed ID: 23517910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical profile of two types of oral snuff tobacco.
    Brunnemann KD; Qi J; Hoffmann D
    Food Chem Toxicol; 2002 Nov; 40(11):1699-703. PubMed ID: 12176096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of carcinogenic tobacco-specific nitrosamines in mainstream smoke from U.S.-brand and non-U.S.-brand cigarettes from 14 countries.
    Wu W; Zhang L; Jain RB; Ashley DL; Watson CH
    Nicotine Tob Res; 2005 Jun; 7(3):443-51. PubMed ID: 16085512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of storage conditions on nitrosated, acylated, and oxidized pyridine alkaloid derivatives in smokeless tobacco products.
    Andersen RA; Burton HR; Fleming PD; Hamilton-Kemp TR
    Cancer Res; 1989 Nov; 49(21):5895-900. PubMed ID: 2790803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinogenic nitrosamines in oral snuff.
    Hoffmann D; Brunnemann KD; Venitt S
    Lancet; 1988 May; 1(8596):1232. PubMed ID: 2897047
    [No Abstract]   [Full Text] [Related]  

  • 35. Free nicotine content and strategic marketing of moist snuff tobacco products in the United States: 2000-2006.
    Alpert HR; Koh H; Connolly GN
    Tob Control; 2008 Oct; 17(5):332-8. PubMed ID: 18669556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The occurrence of N-nitrosocompounds [corrected] in zarda tobacco.
    Tricker AR; Preussmann R
    Cancer Lett; 1988; 42(1-2):113-8. PubMed ID: 3242503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Survey of N'-Nitrosonornicotine (NNN) and Total Water Content in Select Smokeless Tobacco Products Purchased in the United States in 2015.
    Ammann JR; Lovejoy KS; Walters MJ; Holman MR
    J Agric Food Chem; 2016 Jun; 64(21):4400-6. PubMed ID: 27192054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoting effect of snuff in rats initiated by 4-nitroquinoline-N-oxide or 7,12-dimethylbenz(a)anthracene.
    Johansson SL; Saidi J; Osterdahl BG; Smith RA
    Cancer Res; 1991 Aug; 51(16):4388-94. PubMed ID: 1907884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and analysis of a new tobacco-specific N-nitrosamine, 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol.
    Brunnemann KD; Genoble L; Hoffmann D
    Carcinogenesis; 1987 Mar; 8(3):465-9. PubMed ID: 3815741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content.
    Richter P; Spierto FW
    Nicotine Tob Res; 2003 Dec; 5(6):885-9. PubMed ID: 14668072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.